Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study

David W. Dodick, Alexander Mauskop, Arthur H. Elkind, Ronald DeGryse, Mitchell F. Brin, Stephen D. Silberstein

Research output: Contribution to journal › Article › peer-review

182 Scopus citations

Fingerprint

Dive into the research topics of 'Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences